PVAM
CLVS

Pacific View Asset Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Pacific View Asset Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-10,393
Closed -$305K – 90
2018
Q3 		$305K Buy
10,393
+4,458
+75% +$173K 0.24% 75
2018
Q2 		$269K Buy
5,935
+1,707
+40% +$83K 0.21% 89
2018
Q1 		$224K Sell
4,228
-13,233
-76% -$772K 0.17% 106
2017
Q4 		$1.19M Buy
+17,461
New +$1.22M 0.79% 28

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Pacific View Asset Management's CLVS Position: Q4 2018 in Review

Pacific View Asset Management sold out of Clovis Oncology, Inc. (CLVS) in Q4 2018, closing a stake of 10,393 shares — an estimated $305K sold.

Pacific View Asset Management first reported a position in CLVS in Q4 2017 and held it in 4 quarters. The position peaked at $1.19M in Q4 2017. 165 funds tracked by Wall St. Rank hold CLVS as of Q4 2018.

  • Pacific View Asset Management reported no remaining Clovis Oncology, Inc. position as of Q4 2018 after selling out during the quarter.
  • Pacific View Asset Management sold 10,393 Clovis Oncology, Inc. shares in Q4 2018, an estimated $305K.
  • Pacific View Asset Management first reported a position in Clovis Oncology, Inc. in Q4 2017 and held it in 4 quarters.
  • Pacific View Asset Management's Clovis Oncology, Inc. position peaked at $1.19M in Q4 2017.
  • 165 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2018.

Based on Pacific View Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.